Published in Lancet on June 13, 1981
Current issues in the design and interpretation of clinical trials. Br Med J (Clin Res Ed) (1985) 1.49
Is copper hepatotoxic in primary biliary cirrhosis? J Clin Pathol (1981) 1.03
What does the antimitochondrial antibody mean? Gut (1982) 1.01
Double blind controlled trial of d-penicillamine in patients with primary biliary cirrhosis. Gut (1985) 0.98
HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut (1985) 0.92
D-penicillamine for primary biliary cirrhosis. Gut (1985) 0.83
Copper chelation therapy in intrahepatic cholestasis of childhood. Gut (1983) 0.78
Liver transplantation and primary biliary cirrhosis. Postgrad Med J (1989) 0.78
Traditional management of liver disorders. Drugs (1990) 0.77
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis. Oncotarget (2015) 0.76
Recurrent bacteriuria and primary biliary cirrhosis: ABO blood group, P1 blood group, and secretor status. J Clin Pathol (1984) 0.75
Lethargy in a patient with cirrhosis. Postgrad Med J (1997) 0.75
Primary biliary cirrhosis. Br Med J (Clin Res Ed) (1981) 0.75
Primary biliary cirrhosis. Br Med J (Clin Res Ed) (1982) 0.75
Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol (1966) 8.26
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
A classification of chronic hepatitis. Lancet (1968) 6.07
A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut (2004) 5.97
Examination and characterization of distribution system biofilms. Appl Environ Microbiol (1987) 5.85
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41
Occurrence of Giardia and Cryptosporidium spp. in surface water supplies. Appl Environ Microbiol (1991) 5.31
Cellular immunity and hepatitis-associated, Australia antigen liver disease. Lancet (1972) 5.17
Microsatellite evolution--evidence for directionality and variation in rate between species. Nat Genet (1995) 4.77
Incidence and preventability of adverse drug events in nursing homes. Am J Med (2000) 4.33
Inactivation of biofilm bacteria. Appl Environ Microbiol (1988) 4.29
The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci U S A (1998) 4.20
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
The PDB data uniformity project. Nucleic Acids Res (2001) 3.65
Using data from the 1991 census. BMJ (1995) 3.63
Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med (1971) 3.23
Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19
Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14
Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci (1975) 3.13
Risk factors for adverse drug events among nursing home residents. Arch Intern Med (2001) 3.12
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
Loss of employment and mortality. BMJ (1994) 3.06
Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med (1988) 3.01
Giardia and Cryptosporidium spp. in filtered drinking water supplies. Appl Environ Microbiol (1991) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet (1977) 2.90
Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90
Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90
The epidemiology of testicular cancer in young adults. Am J Epidemiol (1980) 2.90
Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85
The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. Q J Med (1979) 2.84
Insulin requirement formula. J Assoc Physicians India (1990) 2.83
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Spread of acute type-B hepatitis in London. Lancet (1973) 2.82
Factors promoting survival of bacteria in chlorinated water supplies. Appl Environ Microbiol (1988) 2.80
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Systematic review: oral bowel preparation for colonoscopy. Aliment Pharmacol Ther (2007) 2.68
Herpes simplex encephalitis: a diagnostic and therapeutic reapprisal. J Assoc Physicians India (1993) 2.68
A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. Am J Gastroenterol (1997) 2.65
Measurement of liver-iron concentration in needle-biopsy specimens. Lancet (1971) 2.65
Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Bacterial nutrients in drinking water. Appl Environ Microbiol (1991) 2.62
Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury. Lancet (1971) 2.61
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology (1975) 2.58
Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57
Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56
The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract (2004) 2.53
Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45
Cell-mediated immunity in patients positive for hepatitis-associated antigen. Br Med J (1972) 2.39
Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36
Niemann-Pick disease type C: diagnosis and outcome in children, with particular reference to liver disease. J Pediatr (1993) 2.32
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
Diagnosis of Gilbert's syndrome: role of reduced caloric intake test. Br Med J (1973) 2.21
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Treatment practices in pulmonary tuberculosis by private sector physicians of Meerut, Uttar Pradesh. Indian J Chest Dis Allied Sci (2012) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut (1995) 2.10
Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J Biol Chem (1997) 2.10
Microkeratome-assisted posterior keratoplasty. J Cataract Refract Surg (2001) 2.09
Complications of diuretic therapy in hepatic cirrhosis. Lancet (1966) 2.09
Helicopter Emergency Ambulance Service (HEAS) transfer: an analysis of trauma patient case-mix, injury severity and outcome. Ann R Coll Surg Engl (2007) 2.08
What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07
Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond) (2009) 2.05
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma. Leukemia (2007) 2.03
Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med (1992) 2.01
Outbreak of polyarthritis with pyrexia in Western Rajasthan. J Assoc Physicians India (2001) 2.01
Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00